• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK; IN-VITRO DIAGNOSTICS Back to Search Results
Model Number 6802892
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/21/2023
Event Type  malfunction  
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solution center (tsc) to report higher than expected vitros intact pth (ipth) results were obtained from several patient samples when tested on a vitros 5600 integrated system.Vitros ipth lot 1776, patient 1 result of 84.51 pg/ml versus the expected non-vitros beckman result of 40 pg/ml and 59.6 pg/ml.Vitros ipth lot 1776, patient 2 result of 227.9 pg/ml versus the expected non-vitros beckman result of 148.2 pg/ml vitros ipth lot 1776, patient 3 result of 174.5 pg/ml versus the expected non-vitros beckman result of 117.5 pg/ml vitros ipth lot 1776, patient 5 result of 158.3 pg/ml versus the expected non-vitros beckman result of 103.4 pg/ml biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The higher than expected results were not reported from the laboratory.Ortho has not been made aware of any allegation of patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4) and reportability assessment (b)(4).
 
Manufacturer Narrative
The investigation determined that higher than expected vitros intact pth (ipth) results were obtained from several patient samples when tested on a vitros 5600 integrated system.A definitive assignable cause could not be determined with the information provided.The customer did not perform any precision testing on the instrument, so no assessment of the instrument performance at the time of the events was made.Therefore, an instrument issue could not be ruled out as contributing to the event.The customer uses a non-vitros beckman system at an alternative site to retest the vitros ipth samples.The time difference between the two sites is approximately 9 hours and the samples are frozen before shipping.The vitros ipth is labile and susceptible to fragmentation.Correct handling of patient samples is necessary to ensure that the pth molecule remains intact.The degree of fragmentation will depend on both time and temperature of storage.Therefore, it is possible that improper sample handling between testing events contributed to the higher-than-expected patient sample results, however, this cannot be confirmed.In addition, the customer is not following the manufacturer¿s recommended sample handling protocol; therefore, incorrect pre-analytical sample handling could have contributed to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples.Continual tracking and trending of complaints has not identified any signals that would indicate a potential systematic issue with vitros ipth reagent lot 1776.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS, INC.
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
microtyping systems
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key17343180
MDR Text Key319702656
Report Number3007111389-2023-00119
Device Sequence Number1
Product Code CEW
UDI-Device Identifier10758750006267
UDI-Public10758750006267
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/18/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/19/2023
Device Model Number6802892
Device Catalogue Number6802892
Device Lot Number1776
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/21/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/05/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-